An optimised lipid nanoparticle platform enables efficient CRISPR/Cas9 genome editing in hard-to-transfect cells.

Saved in:
Bibliographic Details
Title: An optimised lipid nanoparticle platform enables efficient CRISPR/Cas9 genome editing in hard-to-transfect cells.
Authors: Yang X; School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, 2007, Australia., Sang R; Graduate School of Biomedical Engineering, Faculty of Engineering, UNSW Sydney, NSW, 2052, Australia., Hutvagner G; School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, 2007, Australia., Hewitt AW; Menzies Institute for Medical Research, University of Tasmania, TAS, 7005, Australia., Li D; Department of Academic Research, Beijing Ditan Hospital, Capital Medical University, National Center for Infectious Diseases (BeiJing), 8th Jingshun East Road, Beijing, 100015, China., Li Y; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, 1 Yixueyuan Rd., Chongqing, 400016, China; Department of Nephrology, Metabolism and Immunology Laboratory for Urological Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Deng W; School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, 2007, Australia. Electronic address: wei.deng@uts.edu.au.
Source: Acta biomaterialia [Acta Biomater] 2026 May 28. Date of Electronic Publication: 2026 May 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568 (Electronic) Linking ISSN: 17427061 NLM ISO Abbreviation: Acta Biomater Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-7568
DOI:10.1016/j.actbio.2026.05.044